Page last updated: 2024-08-21

podophyllotoxin and tamoxifen

podophyllotoxin has been researched along with tamoxifen in 12 studies

Research

Studies (12)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (25.00)	18.2507
2000's	1 (8.33)	29.6817
2010's	7 (58.33)	24.3611
2020's	1 (8.33)	2.80

Authors

Authors	Studies
Hansch, C; Khwaja, TA; Selassie, CD	1
Goldbrunner, M; Loidl, G; Mannschreck, A; Polossek, T; von Angerer, E	1
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL	1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Chanda, D; Chanotiya, CS; Gupta, A; Kaur, T; Khan, F; Luqman, S; Negi, AS; Prakasham, AP; Saxena, AK; Shanker, K; Yadav, DK	1
Akula, B; Bharathi, EV; Billa, VK; Cosenza, SC; Gallo, JM; Lv, H; Mallireddigari, MR; Padgaonkar, A; Pallela, VR; Reddy, EP; Reddy, MV; Subbaiah, DR	1
Chanda, D; Hasanain, M; Khan, F; Konwar, R; Kumar, A; Luqman, S; Masood, N; Mitra, K; Negi, AS; Pal, A; Sarkar, J; Sathish Kumar, B; Singh, A; Singh, J; Yadav, DK	1
Behera, C; Chanda, D; Fatima, K; Gupta, AK; Hasanain, M; Khwaja, S; Kour, A; Luqman, S; Mondhe, DM; Negi, AS; Sarkar, J; Shanker, K; Singh, A	1
Blanchet, M; Bourguet-Kondracki, ML; Brunel, JM; Cadelis, MM; Copp, BR; Li, SA; Sue, K; Vidal, N	1
Liu, Y; Xu, Z; Zhao, SJ	1
Chanda, D; Dudi, RK; Fatima, K; Iqbal, H; Khan, F; Kumar, Y; Luqman, S; Mondhe, DM; Negi, AS; Shanker, K; Tabassum, M; Verma, AK	1
Albain, KS; Le Beau, MM; Schumacher, H; Ullirsch, R	1

Reviews

2 review(s) available for podophyllotoxin and tamoxifen

Article	Year
1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships. European journal of medicinal chemistry, 2019, Dec-01, Volume: 183 Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles	2019
Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation. Genes, chromosomes & cancer, 1990, Volume: 2, Issue:1 Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Iatrogenic Disease; Leukemia, Monocytic, Acute; Mastectomy, Radical; Middle Aged; Podophyllotoxin; Radiotherapy; Tamoxifen; Topoisomerase II Inhibitors; Translocation, Genetic	1990

Article

Year

1,2,3-Triazole-containing hybrids as potential anticancer agents: Current developments, action mechanisms and structure-activity relationships.

European journal of medicinal chemistry, 2019, Dec-01, Volume: 183

Topics: Antineoplastic Agents; Humans; Molecular Structure; Neoplasms; Structure-Activity Relationship; Triazoles

2019

Implication of prior treatment with drug combinations including inhibitors of topoisomerase II in therapy-related monocytic leukemia with a 9;11 translocation.

Genes, chromosomes & cancer, 1990, Volume: 2, Issue:1

Topics: Alkylating Agents; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 9; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Doxorubicin; Humans; Iatrogenic Disease; Leukemia, Monocytic, Acute; Mastectomy, Radical; Middle Aged; Podophyllotoxin; Radiotherapy; Tamoxifen; Topoisomerase II Inhibitors; Translocation, Genetic

1990

Other Studies

10 other study(ies) available for podophyllotoxin and tamoxifen

Article	Year
Structure-activity relationships of antineoplastic agents in multidrug resistance. Journal of medicinal chemistry, 1990, Volume: 33, Issue:7 Topics: Animals; Antineoplastic Agents; Cell Line; Cell Survival; Cricetinae; Dactinomycin; Drug Resistance; Leukemia L1210; Mice; Regression Analysis; Structure-Activity Relationship; Tumor Cells, Cultured	1990
Inhibition of tubulin polymerization by 5,6-dihydroindolo[2,1-alpha]isoquinoline derivatives. Journal of medicinal chemistry, 1997, Oct-24, Volume: 40, Issue:22 Topics: Animals; Antineoplastic Agents; Cattle; Colchicine; Humans; Indoles; Isoquinolines; Magnetic Resonance Spectroscopy; Molecular Structure; Polymers; Protein Binding; Spectrophotometry, Infrared; Tubulin; Tubulin Modulators; Tumor Cells, Cultured	1997
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling. Current drug discovery technologies, 2004, Volume: 1, Issue:4 Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration	2004
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010
Synthesis and anticancer activity of 2-benzylidene indanones through inhibiting tubulin polymerization. Bioorganic & medicinal chemistry, 2012, May-01, Volume: 20, Issue:9 Topics: Administration, Oral; Animals; Antineoplastic Agents; Benzodioxoles; Benzylidene Compounds; Binding Sites; Cell Line, Tumor; Cell Proliferation; Computer Simulation; Humans; Indans; Mice; Protein Structure, Tertiary; Tubulin; Tubulin Modulators	2012
Design, synthesis, and biological evaluation of (E)-N-aryl-2-arylethenesulfonamide analogues as potent and orally bioavailable microtubule-targeted anticancer agents. Journal of medicinal chemistry, 2013, Jul-11, Volume: 56, Issue:13 Topics: Administration, Oral; Animals; Antineoplastic Agents; Biological Availability; Blood-Brain Barrier; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Drug Design; Drug Resistance, Neoplasm; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Mice; Mice, Nude; Microtubules; Neoplasms; Polymerization; Sulfonamides; Tubulin; Tumor Burden; Xenograft Model Antitumor Assays	2013
Synthesis of neolignans as microtubule stabilisers. Bioorganic & medicinal chemistry, 2014, Feb-15, Volume: 22, Issue:4 Topics: Administration, Oral; Animals; Antineoplastic Agents; Binding Sites; Body Weight; Cell Line, Tumor; Coumaric Acids; Female; G2 Phase Cell Cycle Checkpoints; Half-Life; Humans; Lignans; M Phase Cell Cycle Checkpoints; Male; MCF-7 Cells; Mice; Molecular Docking Simulation; Protein Stability; Protein Structure, Tertiary; Tubulin	2014
Antiproliferative efficacy of curcumin mimics through microtubule destabilization. European journal of medicinal chemistry, 2018, May-10, Volume: 151 Topics: Animals; Antineoplastic Agents; Carcinoma, Ehrlich Tumor; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Screening Assays, Antitumor; Female; Humans; Male; Mice; Microtubules; Neoplasms	2018
6-Bromoindolglyoxylamido derivatives as antimicrobial agents and antibiotic enhancers. Bioorganic & medicinal chemistry, 2019, 05-15, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Cell Line; Cell Survival; Drug Resistance, Bacterial; Erythrocytes; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hemolysis; Humans; Indoles; Microbial Sensitivity Tests; Polyamines	2019
Antiproliferative activity of diarylnaphthylpyrrolidine derivative via dual target inhibition. European journal of medicinal chemistry, 2020, Feb-15, Volume: 188 Topics: Animals; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Drug Screening Assays, Antitumor; Female; G2 Phase Cell Cycle Checkpoints; Humans; Male; Mice; Molecular Docking Simulation; Naphthalenes; Pyrrolidines; Topoisomerase II Inhibitors; Tubulin Modulators	2020